Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.
Benvenuto G, Todeschini P, Paracchini L, Calura E, Fruscio R, Romani C, Beltrame L, Martini P, Ravaggi A, Ceppi L, Sales G, Donati F, Perego P, Zanotti L, Ballabio S, Grassi T, Delle Marchette M, Tognon G, Sartori E, Adorni M, Odicino F, D'Incalci M, Bignotti E, Romualdi C, Marchini S. Benvenuto G, et al. Among authors: odicino f. Int J Cancer. 2020 Jul 15;147(2):565-574. doi: 10.1002/ijc.32935. Epub 2020 Mar 13. Int J Cancer. 2020. PMID: 32096871
Interval debulking surgery in advanced epithelial ovarian cancer.
Pecorelli S, Odicino F, Favalli G. Pecorelli S, et al. Among authors: odicino f. Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):573-83. doi: 10.1053/beog.2002.0302. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12413935 Review.
Consolidation therapies revisited: weekly paclitaxel.
Pecorelli S, Odicino F, Favalli G. Pecorelli S, et al. Among authors: odicino f. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:208-11. doi: 10.1111/j.1525-1438.2003.13365.x. Int J Gynecol Cancer. 2003. PMID: 14656282
Cervical cancer staging.
Pecorelli S, Odicino F. Pecorelli S, et al. Among authors: odicino f. Cancer J. 2003 Sep-Oct;9(5):390-4. doi: 10.1097/00130404-200309000-00009. Cancer J. 2003. PMID: 14690314 Review.
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients.
Ravaggi A, Romani C, Pasinetti B, Tassi RA, Bignotti E, Bandiera E, Odicino FE, Ragnoli M, Donzelli C, Falchetti M, Calza S, Santin AD, Pecorelli S. Ravaggi A, et al. Among authors: odicino fe. Arch Virol. 2006 Oct;151(10):1899-916. doi: 10.1007/s00705-006-0787-y. Epub 2006 May 29. Arch Virol. 2006. PMID: 16732494
HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization.
Odicino FE, Bignotti E, Rossi E, Pasinetti B, Tassi RA, Donzelli C, Falchetti M, Fontana P, Grigolato PG, Pecorelli S. Odicino FE, et al. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):14-21. doi: 10.1111/j.1525-1438.2007.00946.x. Epub 2007 Apr 19. Int J Gynecol Cancer. 2008. PMID: 17451461
New development of the FIGO staging system.
Odicino F, Tisi G, Rampinelli F, Miscioscia R, Sartori E, Pecorelli S. Odicino F, et al. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S8-9. doi: 10.1016/j.ygyno.2007.07.018. Epub 2007 Aug 29. Gynecol Oncol. 2007. PMID: 17761268 No abstract available.
159 results